Proarrhythmic Risk Assessment of Sildenafil under High-Dose Misuse Conditions Using the Comprehensive In Vitro Proarrhythmia Assay (CiPA)
Year: 2026
Type: article
Abstract: . Despite low in silico TdP predictions, functional assays suggest that high concentrations of sildenafil as in misuse may pose a clinically relevant risk of QT prolongation and arrhythmia.
Source: Biomolecules & Therapeutics
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funder: Ministry of Food and Drug Safety
Award: G7492501504
OpenAlex ID: W7158797525
FWCI:
Cites:
Cited by:
Related to:
